Evidence map›Paper›PMID 32317400›Full record

Observational studyJournal of neurology, neurosurgery, and psychiatry2020

Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme.

Thomas Meyer, Dagmar Kettemann, André Maier, Torsten Grehl, Ute Weyen, Julian Grosskreutz, Robert Steinbach, Jenny Norden, Annette George, Andreas Hermann and 8 more

Abstract readLetterMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of neurology, neurosurgery, and psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Thomas MeyerDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany thomas.meyer@charite.de.ORCID 0000-0002-2736-7350
Dagmar KettemannDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
André MaierDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-2473-4116
Torsten GrehlDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Alfried Krupp Krankenhaus, Essen, Germany.
Ute WeyenDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Berufsgenossenschaftliches Universitatsklinikum Bergmannsheil, Bochum, Germany.
Julian GrosskreutzHans Berger Department of Neurology, Jena University Hospital, Jena, Germany.ORCID 0000-0001-9525-1424
Robert SteinbachHans Berger Department of Neurology, Jena University Hospital, Jena, Germany.
Jenny NordenDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Annette GeorgeDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Andreas HermannDepartment of Neurology, Translational Neurodegeneration Section Albrecht Kossel, Universitätsmedizin Rostock, Rostock, Germany.ORCID 0000-0002-7364-7791
René GuentherDepartment of Neurology, Technische Universität Dresden, Dresden, Germany.
Susanne PetriDepartment of Neurology, Hannover Medical School, Hannover, Germany.
Olivia Schreiber-KatzDepartment of Neurology, Hannover Medical School, Hannover, Germany.
Johannes DorstDepartment of Neurology, University of Ulm, Ulm, Germany.
Albert C LudolphDepartment of Neurology, University of Ulm, Ulm, Germany.ORCID 0000-0002-5401-0904
Bertram WalterDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christoph MünchDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Susanne SpittelDepartment of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-9471-7798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAmyotrophic Lateral SclerosisCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeuroprotective AgentsProspective StudiesRiluzoleTreatment OutcomeNeuroprotective AgentsRiluzoleALSmotor neuron disease

Identifiers

PMID32317400
PMCPMC7361015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.